Franklin Resources’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $807K | Buy |
70,861
+9,352
| +15% | +$107K | ﹤0.01% | 2085 |
|
2025
Q1 | $731K | Sell |
61,509
-58,936
| -49% | -$700K | ﹤0.01% | 2092 |
|
2024
Q4 | $2.27M | Sell |
120,445
-2,656
| -2% | -$50K | ﹤0.01% | 1681 |
|
2024
Q3 | $3.1M | Buy |
123,101
+42,315
| +52% | +$1.06M | ﹤0.01% | 1562 |
|
2024
Q2 | $1.69M | Buy |
80,786
+16,314
| +25% | +$340K | ﹤0.01% | 1748 |
|
2024
Q1 | $948K | Buy |
64,472
+41,851
| +185% | +$615K | ﹤0.01% | 1971 |
|
2023
Q4 | $233K | Sell |
22,621
-11
| -0% | -$114 | ﹤0.01% | 2283 |
|
2023
Q3 | $178K | Sell |
22,632
-259
| -1% | -$2.04K | ﹤0.01% | 2343 |
|
2023
Q2 | $229K | Buy |
+22,891
| New | +$229K | ﹤0.01% | 2314 |
|